ONO 1078
Tocris Bioscience, part of Bio-Techne | Catalog # 3026
Selective CysLT1 antagonist; also TREK2 activator
Discontinued Product
3026 has been discontinued.
View all Leukotriene and Related Receptor Antagonists products.
Key Product Details
Description
Selective CysLT1 antagonist; also TREK2 activator
Alternative Names
Pranlukast
Product Description
ONO 1078 is a selective cysteinyl leukotriene receptor 1 (CysLT1) antagonist (IC50 values are ~ 4 - 7 and 3620 nM for CysLT1 and CysLT2 respectively). Inhibits contraction of airway smooth muscle, microvascular leakage into airways and eosinophil infiltration. Can decrease symptoms of bronchial asthma. Also TREK2 activator (pEC50 = 5.8); exhibits selectivity for TREK-2 over other K2P channels.Product Specifications
Molecular Weight
481.50
Formula
C27H23N5O4
Storage
Store at +4°C
Purity
≥99% (HPLC)
Chemical Name
N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4(4-phenylbutoxy)benzamide
CAS Number
103177-37-3
PubChem ID
4887
InChI Key
NBQKINXMPLXUET-UHFFFAOYSA-N
SMILES
O=C2C1=CC=CC(NC(C4=CC=C(OCCCCC5=CC=CC=C5)C=C4)=O)=C1OC(C3=NN=NN3)=C2
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Solubility
| Solvent | Max Conc. mg/mL | Max Conc. mM | |
|---|---|---|---|
| Solubility | |||
| DMSO | 24.07 | 50 |
Preparing Stock Solutions
for ONO 1078
The following data is based on the product molecular weight 481.50
Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which all affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.5 mM | 4.15 mL | 20.77 mL | 41.54 mL |
| 2.5 mM | 0.83 mL | 4.15 mL | 8.31 mL |
| 5 mM | 0.42 mL | 2.08 mL | 4.15 mL |
| 25 mM | 0.08 mL | 0.42 mL | 0.83 mL |
Calculators
Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Background References
References are publications that support the biological activity of the product.
- Wright Pranlukast is a novel small molecule activator of the two-pore domain potassium channel TREK2. Biochem.Biophys.Res.Commun. 2019 PMID: 31564414
- Heise Characterization of the human cysteinyl leukotriene 2 receptor. J.Biol.Chem. 2000 PMID: 10851239
- Suzuki Inhibition of human eosinophil activation by a cysteinyl leukotriene receptor antagonist (Pranlukast; ONO-1078). J.Asthma 2003 PMID: 12870835
- Lynch Characterization of the human leukotriene CysLT1 receptor. Nature 1999 PMID: 10391245
Product Specific Notices for ONO 1078
For research use only
Loading...
Loading...